Additionally, semaglutide demonstrated neuroprotective benefits to the CNS leading to enhancement to cell survival, decreased M1-like microglia numbers, and reduced interleukin-6 and TNF- levels in different brain areas in obesity (Tamayo-Trujillo et al
La medicacin que se utiliza aqu para obesidad es liraglutida, que tambin es un agonista de GLP-1 pero es de aplicacin diaria, a diferencia de semaglutida, que es de aplicacin semanal
When you cannot get your standard dose, microdosing becomes a survival strategy
In summary, proving a complete separation and a hard border between the peripheral and central GLP1 system encounters a variety of difficulties, which prevent us from coming to watertight conclusions
In individuals with type 2 diabetes treated with insulin, CGM, both intermittently scanned CGM and real-time CGM, has gained traction, with evidence that CGM results in better overall glucose control as defined by HbA 1c and time in range (3.910.0 mmol/l [70180 mg/dl]), fewer hyperglycaemic and hypoglycaemic episodes and improvements in diabetes distress [336, 337]
The Medicare GLP-1 Bridge program will cover Zepbound, but only when doctors prescribe a version called the KwikPen